We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Life Sciences/MALDI-TOF-Mass Spectrometry Applications in Clinical Microbiology
PeriodicalsLife Sciences

MALDI-TOF-Mass Spectrometry Applications in Clinical Microbiology

Checking your access to this record.

Abstract & Overview

MALDI-TOF-mass spectrometry (MS) has been successfully adapted for the routine identification of microorganisms in clinical microbiology laboratories in the past 10 years. This revolutionary technique allows for easier and faster diagnosis of human pathogens than conventional phenotypic and molecular identification methods, with unquestionable reliability and cost-effectiveness. This article will review the application of MALDI-TOF-MS tools in routine clinical diagnosis, including the identification of bacteria at the species, subspecies, strain and lineage levels, and the identification of bacterial toxins and antibiotic-resistance type. We will also discuss the application of MALDI-TOF-MS tools in the identification of Archaea, eukaryotes and viruses. Pathogenic identification from colony-cultured, blood-cultured, urine and environmental samples is also reviewed.

Cite this record

Piseth Seng, Jean‐Marc Rolain, Pierre‐Edouard Fournier, Bernard La Scola, Michel Drancourt, Didier Raoult (2010). MALDI-TOF-Mass Spectrometry Applications in Clinical Microbiology. Future Microbiology, 5(11), 1733–1754. https://doi.org/10.2217/fmb.10.127

Copy in another style

Seng, P., Rolain, J., Fournier, P., Scola, B. L., Drancourt, M., & Raoult, D. (2010). MALDI-TOF-Mass Spectrometry Applications in Clinical Microbiology. Future Microbiology, 5(11), 1733–1754. https://doi.org/10.2217/fmb.10.127
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.